The DOI matches its Crossref record; 275 of the 275 references it cites were found in a registry or an index.
Small Molecule Modulators of Keap1‐ Nrf2‐ ARE Pathway as Potential Preventive and Therapeutic Agents
Open accessAbstract
Kelch-like ECH-associated protein 1 (Keap1)-nuclear factor erythroid 2-related factor 2 (Nrf2)-antioxidant response elements (ARE) pathway represents one of the most important cellular defense mechanisms against oxidative stress and xenobiotic damage. Activation of Nrf2 signaling induces the transcriptional regulation of ARE-dependent expression of various detoxifying and antioxidant defense enzymes and proteins. Keap1-Nrf2-ARE signaling has become an attractive target for the prevention and treatment of oxidative stress-related diseases and conditions including cancer, neurodegenerative, cardiovascular, metabolic, and inflammatory diseases. Over the last few decades, numerous Nrf2 inducers have been developed and some of them are currently undergoing clinical trials. Recently, overactivation of Nrf2 has been implicated in cancer progression as well as in drug resistance to cancer chemotherapy. Thus, Nrf2 inhibitors could potentially be used to improve the effectiveness of cancer therapy. Herein, we review the signaling mechanism of Keap1-Nrf2-ARE pathway, its disease relevance, and currently known classes of small molecule modulators. We also discuss several aspects of Keap1-Nrf2 interaction, Nrf2-based peptide inhibitor design, and the screening assays currently used for the discovery of direct inhibitors of Keap1-Nrf2 interaction.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Mitochondria are responsible for the production of the majority of ROS within a cell, and these potentially harmful radicals are modulated by the expression of endogenous antioxidants involving the nuclear factor erythroid 2-related factor 2 (Nrf2)- kelch-like ECH-associated protein 1 (Keap1) pathway [Magesh et al., 2012] or via external anti-oxidants in the diet [Birch-Machin and Oyewole 2015;”
From Oxidative stress and ageing (2016) · cites this paper as Magesh et al., 2012
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
2 retracted
Items 201–275 of 275
Negi, G., Kumar, A., Joshi, R. P., & Sharma, S. S. (2011) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2011.03.087 · Cited by 140
Wang, X.-J., Sun, Z., Chen, W., Li, Y., Villeneuve, N. F., & Zhang, D. D. (2008) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2008.03.003 · Cited by 135
Antioxidant and cytoprotective responses to redox stress
Mathers, J. E., Fraser, J. A., McMahon, M. J., Saunders, R. D. C., Hayes, J. D., & McLellan, L. I. (2004) · Biochemical Society Symposia · doi:10.1042/bss0710157 · Cited by 134 · cited 1×
“217 Other catechol-type antioxidant compounds, such as purpurogallin carboxylate175 (56), nordihydroguaiaretic acid175, 218 (57),160, 203 1,2-naphthoquinone (58),219 and its natural diterpene derivative tanshinone IIA (59),175 were also shown to activate Nrf2 and upregulate some of the Nrf2s downstream genes.”
BackgroundThe Double-Edged Sword of Nrf2: Subversion of Redox Homeostasis during the Evolution of Cancer
Hayes, J. D., & McMahon, M. J. (2006) · Molecular Cell · doi:10.1016/j.molcel.2006.03.004 · Cited by 134
NRF2, cancer and calorie restriction
Martín‐Montalvo, A., Villalba, J. M., Navas, P., & de Cabo, R. (2010) · Oncogene · doi:10.1038/onc.2010.492 · Cited by 129 · cited 2×
“It was also suggested that diphenols undergo cytochrome P450-mediated oxidation in vivo to form quinones as the ultimate inducers.202 Endogenous p- and o-hydroquinones, such as catechol estrogens (44), dopamine (45), and L-DOPA (46), also have been shown to induce ARE-dependent defensive responses.202 (S)-(+)-Apomorph…”
BackgroundFisher, C. D., Augustine, L. M., Maher, J. M., Nelson, D. M., Slitt, A. L., Klaassen, C. D., Lehman‐McKeeman, L. D., & Cherrington, N. J. (2007) · Drug Metabolism and Disposition · doi:10.1124/dmd.106.014340 · Cited by 128
Chemical Structures of Inducers of Nicotinamide Quinone Oxidoreductase 1 (NQO1)
Dinkova‐Kostova, A. T., Fahey, J. W., & Talalay, P. (2004) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/s0076-6879(04)82023-8 · Cited by 126
Zhang, Y., Crouch, D. H., Yamamoto, M. P., & Hayes, J. D. (2006) · Biochemical Journal · doi:10.1042/bj20060725 · Cited by 124
Active defense under oxidative stress. The antioxidant responsive element
Lyakhovich, V. V., Андреевич, В. В., Зенков, Н. К., & Брониславовна, М. Е. (2006) · Biochemistry (Moscow) · doi:10.1134/s0006297906090033 · Cited by 123 · cited 1×
“A number of flavonoids have been reported to have ARE gene-induction properties; these include synthetic flavonoids such as 4-bromo flavone (13)178 and β-naphthoflavone (14),32 a natural isoflavone sappanone A (15),175 and flavonoids-like benzofuran-containing substituted aurones (16)177 and their corresponding indole…”
BackgroundSong, L. L., Kosmeder, J. W., Lee, S. K., Gerhäuser, C., Lantvit, D. D., Moon, R. C., Moriarty, R. M., & Pezzuto, J. M. (1999) · PubMed · Cited by 122
Neuroscience and Hormesis: Overview and General Findings
Calabrese, E. J. (2008) · Critical Reviews in Toxicology · doi:10.1080/10408440801981957 · Cited by 121
Lee, S. E., Jeong, S. I., Yang, H., Park, C., Jin, Y., & Park, Y. S. (2011) · Journal of Cellular Biochemistry · doi:10.1002/jcb.23158 · Cited by 115
Prohibitin Is a Novel Regulator of Antioxidant Response That Attenuates Colonic Inflammation in Mice
Theiss, A. L., Vijay–Kumar, M., Obertone, T. S., Jones, D. P., Hansen, J. M., Gewirtz, A. T., Merlin, D., & Sitaraman, S. V. (2009) · Gastroenterology · doi:10.1053/j.gastro.2009.03.033 · Cited by 113
Wang, X. J., Hayes, J. D., Higgins, L. G., Wolf, C. R., & Dinkova‐Kostova, A. T. (2010) · Chemistry & Biology · doi:10.1016/j.chembiol.2009.12.013 · Cited by 112
Dithiolethiones for cancer chemoprevention: where do we stand?
Zhang, Y., & Munday, R. (2008) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-08-0625 · Cited by 111
Deficiency of Nrf2 Accelerates the Effector Phase of Arthritis and Aggravates Joint Disease
Maicas, N., Ferrándiz, M. L., Brines, R., Ibáñez, L., Cuadrado, A., Koenders, M. I., van den Berg, W. B., & Alcaraz, M. J. (2011) · Antioxidants and Redox Signaling · doi:10.1089/ars.2010.3835 · Cited by 110
Age-associated oxidative damage to the p62 promoter: implications for Alzheimer disease
Du, Y., Wooten, M. C., Gearing, M., & Wooten, M. W. (2008) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2008.11.003 · Cited by 108
Zhang, W., & Go, M. (2008) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2008.12.052 · Cited by 108
An Exceptionally Potent Inducer of Cytoprotective Enzymes
Dinkova‐Kostova, A. T., Talalay, P., Sharkey, J., Zhang, Y., Holtzclaw, W. D., Wang, X. J., David, E., Schiavoni, K. H., Finlayson, S. D., Mierke, D. F., et al. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.163485 · Cited by 106
Inoyama, D., Chen, Y., Huang, X., Beamer, L. J., Kong, A. T., & Hu, L. (2011) · SLAS DISCOVERY · doi:10.1177/1087057111430124 · Cited by 101
Ichikawa, T., Li, J., Meyer, C. J., Janicki, J. S., Hannink, M., & Cui, T. (2009) · PLoS ONE · doi:10.1371/journal.pone.0008391 · Cited by 99
Copple, I. M., Goldring, C. E., Kitteringham, N. R., & Park, B. K. (2009) · Handbook of experimental pharmacology · doi:10.1007/978-3-642-00663-0_9 · Cited by 98
Tarumoto, T., Nagai, T., Ohmine, K., Miyoshi, T., Nakamura, M., Kondo, T., Mitsugi, K., Nakano, S., Muroi, K., Komatsu, N., et al. (2004) · Experimental Hematology · doi:10.1016/j.exphem.2004.01.007 · Cited by 97
Smirnova, N. A., Haskew-Layton, R. E., Basso, M., Hushpulian, D. M., Payappilly, J. B., Speer, R. E., Ahn, Y., Rakhman, I., Cole, P. A., Pinto, J. T., et al. (2011) · Chemistry & Biology · doi:10.1016/j.chembiol.2011.03.013 · Cited by 96
Hernandez-Montes, E., Pollard, S. E., Vauzour, D., Jofre‐Monseny, L., Rota, C., Rimbach, G. H., Weinberg, P. D., & Spencer, J. P. E. (2006) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2006.05.197 · Cited by 96
Haridas, V., Hanausek, M., Nishimura, G., Soehnge, H., Gaikwad, A. S., Naróg, M., Spears, E., Żółtaszek, R., Wałaszek, Z., & Gutterman, J. U. (2004) · Journal of Clinical Investigation · doi:10.1172/jci18699 · Cited by 86
Chen, Y., Inoyama, D., Kong, A. T., Beamer, L. J., & Hu, L. (2011) · Chemical Biology & Drug Design · doi:10.1111/j.1747-0285.2011.01240.x · Cited by 85
The Antioxidant Response Element and Oxidative Stress Modifiers in Airway Diseases
Reddy, S. P. (2008) · Current Molecular Medicine · doi:10.2174/156652408785160925 · Cited by 84
Lukosz, M., Jakob, S., Büchner, N., Zschauer, T.-C., Altschmied, J., & Haendeler, J. (2009) · Antioxidants and Redox Signaling · doi:10.1089/ars.2009.2609 · Cited by 83
A Small-Molecule Inducer of the Antioxidant Response Element
Hur, W., Sun, Z., Jiang, T., Mason, D. E., Peters, E. C., Zhang, D. D., Luesch, H., Schultz, P. G., & Gray, N. S. (2010) · Chemistry & Biology · doi:10.1016/j.chembiol.2010.03.013 · Cited by 82
Koenitzer, J. R., & Freeman, B. Α. (2010) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2010.05559.x · Cited by 80
Activation of Antioxidant/Electrophile-Responsive Elements in IMR-32 Human Neuroblastoma Cells
Moehlenkamp, J. D., & Johnson, J. A. (1999) · Archives of Biochemistry and Biophysics · doi:10.1006/abbi.1998.1046 · Cited by 80
Tsujita, T., Li, L., Nakajima, H., Iwamoto, N., Nakajima‐Takagi, Y., Ohashi, K., Kawakami, K., Kumagai, Y., Freeman, B. Α., Yamamoto, M. P., et al. (2010) · Genes to Cells · doi:10.1111/j.1365-2443.2010.01466.x · Cited by 79
Nrf2 is a critical modulator of the innate immune response in a model of uveitis
Nagai, N., Thimmulappa, R. K., Cano, M., Fujihara, M., Izumi‐Nagai, K., Kong, X., Sporn, M. B., Kensler, T. W., Biswal, S. S., & Handa, J. T. (2009) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2009.04.033 · Cited by 79
Lee, E. B., Skovronsky, D., Abtahian, F., Doms, R. W., & Lee, V. M. ‐. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m210105200 · Cited by 78
An Autoregulatory Loop between Nrf2 and Cul3-Rbx1 Controls Their Cellular Abundance
Kaspar, J. W., & Jaiswal, A. K. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.121863 · Cited by 75 · cited 1×
“255 Using a cell-based ARE-reporter assay, luteolin (94) was shown to be a potent Nrf2 inhibitor.”
MethodWesterink, W. M. A., Stevenson, J. C. R., Horbach, G. J., & Schoonen, W. G. E. J. (2009) · Mutation Research/Genetic Toxicology and Environmental Mutagenesis · doi:10.1016/j.mrgentox.2009.12.007 · Cited by 74
Haridas, V., Hanausek, M., Nishimura, G., et al. (2004) · Journal of Clinical Investigation · doi:10.1172/jci200418699 · Cited by 72
Hara, H., Ohta, M., & Adachi, T. (2006) · Journal of Neuroscience Research · doi:10.1002/jnr.20974 · Cited by 71
Honda, T., Yoshizawa, H., Sundararajan, C., David, E., Lajoie, M. J., Favaloro, F. G., Janosik, T., Su, X., Honda, Y., Roebuck, B. D., et al. (2011) · Journal of Medicinal Chemistry · doi:10.1021/jm101445p · Cited by 70
Induction of the Keap1/Nrf2/ARE pathway by oxidizable diphenols
Dinkova‐Kostova, A. T., & Wang, X. J. (2010) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2010.09.010 · Cited by 70
Guzmán‐Beltrán, S., Espada, S., Orozco‐Ibarra, M., Pedraza‐Chaverrí, J., & Cuadrado, A. (2008) · Neuroscience Letters · doi:10.1016/j.neulet.2008.09.079 · Cited by 69
Ochratoxin A impairs Nrf2‐dependent gene expression in porcine kidney tubulus cells
Boesch, C., Wagner, A. E., Graeser, A.-C., Hundhausen, C., Wolffram, S., & Rimbach, G. H. (2008) · Journal of Animal Physiology and Animal Nutrition · doi:10.1111/j.1439-0396.2008.00838.x · Cited by 69
Comparison of citrus coumarins on carcinogen-detoxifying enzymes in Nrf2 knockout mice
Prince, M., Li, Y., Childers, A., Itoh, K., Yamamoto, M. P., & Kleiner, H. E. (2008) · Toxicology Letters · doi:10.1016/j.toxlet.2008.12.014 · Cited by 67
Prawan, A., Keum, Y.-S., Khor, T. O., Yu, S., Nair, S., Li, W., Hu, L., & Kong, A. T. (2007) · Pharmaceutical Research · doi:10.1007/s11095-007-9370-9 · Cited by 65
Miura, T., Shinkai, Y., Jiang, H., Iwamoto, N., Sumi, D., Taguchi, K., Yamamoto, M. P., Jinno, H., Tanaka‐Kagawa, T., Cho, A. K., et al. (2011) · Chemical Research in Toxicology · doi:10.1021/tx100427p · Cited by 65
Yu, A., Lu, C., Wang, T., Tsai, C.-W., Liu, K., Cheng, Y., Chang, H. C.-W., Lii, C., & Chen, H. (2010) · Journal of Agricultural and Food Chemistry · doi:10.1021/jf101353c · Cited by 63
Wang, X., & Hai, C. (2011) · Mini-Reviews in Medical Chemistry · doi:10.2174/138955711797247761 · Cited by 63
Effect of selenium-containing compounds on hepatic chemoprotective enzymes in mice
El-Sayed, W. M., Tarek Aboul-fadl, A., Lamb, J. G., Roberts, J. C., & Franklin, M. R. (2006) · Toxicology · doi:10.1016/j.tox.2005.12.016 · Cited by 62
Liby, K. T., Honda, T., Williams, C. R., Risingsong, R., Royce, D. B., Suh, N., Dinkova‐Kostova, A. T., Stephenson, K. K., Talalay, P., Sundararajan, C., et al. (2007) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-07-0180 · Cited by 60
Kim, N., Oh, M., Park, H., & Kim, I. (2010) · Journal of Pharmacological Sciences · doi:10.1254/jphs.09330fp · Cited by 56
Lee, Y.-M., Jeong, G., Lim, H., An, R., Kim, Y., & Kim, E.-C. (2009) · Toxicology in Vitro · doi:10.1016/j.tiv.2009.12.024 · Cited by 55
Emmert, S. W., Desai, D. H., Amin, S., & Richie, J. P. (2010) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2010.01.044 · Cited by 54
Masutani, H., Otsuki, R., Yamaguchi, Y., Takenaka, M., Kanoh, N., Takatera, K., Kunimoto, Y. K. Y., & Yodoi, J. (2009) · Antioxidants and Redox Signaling · doi:10.1089/ars.2008.2292 · Cited by 52
Chemopreventive promise of targeting the Nrf2 pathway
Yates, M. S., & Kensler, T. W. (2007) · Drug News & Perspectives · doi:10.1358/dnp.2007.20.2.1083437 · Cited by 51
Role of the Nrf2-ARE pathway in acrylamide neurotoxicity
Zhang, L., Gavin, T., Barber, D. S., & LoPachin, R. M. (2011) · Toxicology Letters · doi:10.1016/j.toxlet.2011.04.011 · Cited by 50
Terazawa, R., Garud, D. R., Hamada, N., Fujita, Y., Itoh, T., Nozawa, Y., Nakane, K., Deguchi, T., Koketsu, M., & Ito, M. (2010) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2010.08.019 · Cited by 49
Isoalantolactone from Inula helenium Caused Nrf2-Mediated Induction of Detoxifying Enzymes
Seo, J. Y., Park, J., Kim, H. J., Lee, I. A., Lim, J.-S., Lim, S. S., Choi, S.-J., Park, J. H. Y., Kang, H. J., & Kim, J. (2009) · Journal of Medicinal Food · doi:10.1089/jmf.2009.0072 · Cited by 44
Conserved solvent and side-chain interactions in the 1.35 Å structure of the Kelch domain of Keap1
Beamer, L. J., Li, X., Bottoms, C. A., & Hannink, M. (2005) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444905022626 · Cited by 42
Shibuya, A., Onda, K., Kawahara, H., Uchiyama, Y., Nakayama, H., Omi, T., Nagaoka, M., Matsui, H., & Hirano, T. (2010) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2010.06.124 · Cited by 40
Kelleher, M., McMahon, M. J., Eggleston, I. M., Dixon, M. J., Taguchi, K., Yamamoto, M. P., & Hayes, J. D. (2009) · Carcinogenesis · doi:10.1093/carcin/bgp182 · Cited by 40
Prochaska, H. J., Bregman, H. S., Long, M. J., & Talalay, P. (1985) · Biochemical Pharmacology · doi:10.1016/0006-2952(85)90443-5 · Cited by 36
Control of oxidative stress by the Keap1-Nrf2 pathway
Stewart, J. D., Hengstler, J. G., & Bolt, H. M. (2011) · Archives of Toxicology · doi:10.1007/s00204-011-0694-1 · Cited by 35 · cited 1×
“Sesquiterpenes such as zumberone (18)180 and isoalantolactone (19),181 and terpenoids containing α,β-unsaturated fragrant aldehydes182 such as perillaldehyde (20) and citral (21) were shown to induce Nrf2-mediated expression of detoxifying enzymes.”
BackgroundA novel strategy to activate cytoprotective genes in the injured brain
Zhao, J., Redell, J. B., Moore, A. N., & Dash, P. K. (2011) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2011.03.046 · Cited by 33
A structure–activity relationship study of brusatol, an antitumor quassinoid
Hitotsuyanagi, Y., Kim, I. H., Hasuda, T., Yamauchi, Y., & Takeya, K. (2006) · Tetrahedron · doi:10.1016/j.tet.2006.01.083 · Cited by 31
Kim, S. G., Kim, Y. M., Choi, J. Y., Han, J.-Y., Jang, J. W., Cho, S.-H., Um, S. H., Chon, C. Y., Lee, D. H., Jang, J., et al. (2011) · Journal of Pharmacy and Pharmacology · doi:10.1111/j.2042-7158.2011.01259.x · Cited by 27 · cited 2×
“Polyphenolic compounds are able to directly quench free radical species and were used as antioxidants, even before Keap1-Nrf2-ARE signaling pathway was indentified.196 In late 1970s, a prototypic phenolic antioxidant BHA (40) was found to induce the expression of cytoprotective enzymes.197, 198 Structural modification…”
BackgroundHsieh (1992) · International Journal of Oncology · doi:10.3892/ijo_00000071 · Cited by 25
Jia, Z., Zhu, H., Trush, M. A., Misra, H. P., & Li, Y. (2007) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-007-9598-z · Cited by 24
Dinkova‐Kostova, A. T., Cory, A. H., Bozak, R. E., Hicks, R. J., & Cory, J. G. (2006) · Cancer Letters · doi:10.1016/j.canlet.2006.01.024 · Cited by 24
Honda, T., Dinkova‐Kostova, A. T., David, E., Padegimas, E. M., Sundararajan, C., Visnick, M., Bumeister, R., & Wigley, W. C. (2011) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2011.03.018 · Cited by 19
Disruption of the Keap1-Containing Ubiquitination Complex as an Antioxidant Therapy
Kern, J. T., Hannink, M., & Hess, J. F. (2007) · Current Topics in Medicinal Chemistry · doi:10.2174/156802607780906825 · Cited by 17
Paonessa, J. D., Munday, C. M., Mhawech-Fauceglia, P. Y., Munday, R., & Zhang, Y. (2008) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2008.12.001 · Cited by 15
Screening of potential chemopreventive compounds from Poncirus trifoliata Raf.
Pokharel, Y. R., Jeong, J.-E., Oh, S. J., Kim, S. K., Woo, E., & Kang, K. W. (2006) · PubMed · Cited by 14
Development of a Molecular Assay for Rapid Screening of Chemopreventive Compounds Targeting Nrf2
Wang, Z., Gidwani, V., Sun, Z., Zhang, D. D., & Wong, P. K. (2008) · JALA Journal of the Association for Laboratory Automation · doi:10.1016/j.jala.2008.03.007 · Cited by 13
Wong, D. P. W., Wells, G., & Hagen, T. (2010) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2010.06.040 · Cited by 8
Flagged first, then by citations
Research works printed but not linked: 2
- 10.1038/sj.emboj.7601243 · DOI · Paper page
- 10.1016/j.chembiol.2011.03.013 · DOI
Cited by
Sorted by citations
Chalcone: A Privileged Structure in Medicinal Chemistry
Zhuang, C., Zhang, W., Sheng, C., Zhang, W., Xing, C., & Miao, Z. (2017) · Chemical Reviews · doi:10.1021/acs.chemrev.7b00020 · Cited by 1,538
The emerging role of the Nrf2–Keap1 signaling pathway in cancerPreprint
Jaramillo, M. C., & Zhang, D. D. (2013) · Genes & Development · doi:10.1101/gad.225680.113 · Cited by 1,326
“Several other small molecules have been found to suppress the Nrf2 pathway, including ascorbic acid, luteolin, ochratoxin A, trigonelline, and all-trans retinoic acid (ATRA) (for review, see Magesh et al. 2012).”
BackgroundGlutathione metabolism in cancer progression and treatment resistance
Bansal, A., & Simon, M. C. (2018) · The Journal of Cell Biology · doi:10.1083/jcb.201804161 · Cited by 1,253
“Therefore, more thorough research needs to be performed to discover effective and highly selective inhibitors of NRF2 activity (Magesh et al., 2012).”
BackgroundLu, H., Zhou, Q., He, J., Jiang, Z., Peng, C., Tong, R., & Shi, J. (2020) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-020-00315-3 · Cited by 891
“As a result, the long term application of the Keap1/Nrf2 inhibitors results in the accumulation of the active Nrf2, which may trigger other problems like cancer(178) Therefore, finding non-covalent small molecules that directly interfere with the Keap–Nrf2 interaction, dissociating the two and exerting antioxidant def…”
BackgroundThe Keap1–Nrf2–ARE Pathway As a Potential Preventive and Therapeutic Target: An Update
Lu, M., Ji, J., Jiang, Z., & You, Q. (2016) · Medicinal Research Reviews · doi:10.1002/med.21396 · Cited by 815
Metadata
- Authors
- Magesh, S., Chen, Y., & Hu, L.
- Affiliations
- Rutgers, The State University of New Jersey (US)
- Corresponding author
- Hu, Longqin
- ORCID
- Venue
- Medicinal Research Reviews
- Publisher
- Wiley
- Published
- 2012-05
- Volume
- 32
- Issue
- 4
- Pages
- 687-726
- ISSN
- 0198-6325 (ISSN-L)
- 1098-1128
- PMC
- PMC3393814
- OpenAlex
- W1767659454
- Cited by
- 760
- References
- 275
- Citations by year
- 2026: 30 · 2025: 39 · 2024: 52 · 2023: 61 · 2022: 69 · 2021: 58 · 2020: 85 · 2019: 81 · 2018: 54 · 2017: 63 · 2016: 41 · 2015: 56 · 2014: 42 · 2013: 28 · 2012: 1
- FWCI
- 3.79
- Type
- journal article
- Language
- en
- Open access
- green
- europepmc.org
- Locations
- Medicinal Research Reviews (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institutes of Health (CA133791, CA125868, MH093197)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genomics, phytochemicals, and oxidative stress
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Redox biology and oxidative stress
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Toxicology › Bioactive Compounds and Antitumor Agents
- Keywords
- Nrf2/Keap1 pathway, Nrf2, Keap1, antioxidant response element, small molecule modulators, Nrf2 inducers, Nrf2 inhibitors, oxidative stress, xenobiotic detoxification, antioxidant defense, cancer chemotherapy resistance, peptide inhibitors, Keap1-Nrf2 interaction
- MeSH terms
- Animals, Anti-Inflammatory Agents, Antineoplastic Agents, Antioxidants, Humans, Hypoglycemic Agents, Signal Transduction, Oxidative Stress, Neuroprotective Agents, Response Elements, Intracellular Signaling Peptides and Proteins, NF-E2-Related Factor 2
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review